Literature DB >> 9118700

Sympathetic nervous system alterations in sleep apnea. The relative importance of respiratory disturbance, hypoxia, and sleep quality.

J E Dimsdale1, T Coy, S Ancoli-Israel, P Mills, J Clausen, M G Ziegler.   

Abstract

Numerous alterations in the sympathetic nervous system have been reported in patients with obstructive sleep apnea. It is unclear whether such alterations can be attributed to the respiratory disturbance itself, the resulting hypoxia, or disruption of sleep. We examined urinary norepinephrine levels in 45 individuals with varying amounts of respiratory disturbance and sleep disruption. All were of similar age (40 to 60 years) and body weight (100 to 160% ideal body weight), and all were free from antihypertensive medications that could influence norepinephrine levels. Twenty-four-hour urinary norepinephrine levels were correlated with respiratory disturbance index (r = 0.39, p < 0.01) and mean oxygen saturation (r = -0.36, p < 0.05). These variables, together with the time in slow-wave sleep, accounted for a statistically significant but modest percentage of the variance in urinary norepinephrine (R2 = 0.19, p < 0.05). However, the variables were so tightly intercorrelated that no single variable independently predicted norepinephrine levels in multiple regression analysis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9118700     DOI: 10.1378/chest.111.3.639

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Correlation of daytime sleepiness with urine metabolites in patients with obstructive sleep apnea.

Authors:  Man-Jeong Paik; Dong-Kyu Kim; Duc-Toan Nguyen; Gwang Lee; Chae Seo Rhee; In Young Yoon; Jeong-Whun Kim
Journal:  Sleep Breath       Date:  2014-01-09       Impact factor: 2.816

2.  Resistant hypertension and obstructive sleep apnea in the setting of kidney disease.

Authors:  Khaled Abdel-Kader; Sheena Dohar; Nirav Shah; Manisha Jhamb; Steven E Reis; Patrick Strollo; Daniel Buysse; Mark L Unruh
Journal:  J Hypertens       Date:  2012-05       Impact factor: 4.844

Review 3.  Metabolic consequences of sleep-disordered breathing.

Authors:  Jonathan Jun; Vsevolod Y Polotsky
Journal:  ILAR J       Date:  2009

4.  Glucoregulatory consequences and cardiorespiratory parameters in rats exposed to chronic-intermittent hypoxia: effects of the duration of exposure and losartan.

Authors:  Victor B Fenik; Tyana Singletary; Jennifer L Branconi; Richard O Davies; Leszek Kubin
Journal:  Front Neurol       Date:  2012-04-09       Impact factor: 4.003

5.  Diurnal variability of C-reactive protein in obstructive sleep apnea.

Authors:  Paul J Mills; Loki Natarajan; Roland von Känel; Sonia Ancoli-Israel; Joel E Dimsdale
Journal:  Sleep Breath       Date:  2009-06-17       Impact factor: 2.816

Review 6.  Dynamics of ACTH and Cortisol Secretion and Implications for Disease.

Authors:  Stafford L Lightman; Matthew T Birnie; Becky L Conway-Campbell
Journal:  Endocr Rev       Date:  2020-06-01       Impact factor: 19.871

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.